President & CEO of Illumina, Inc. (
ILMN) Jay T Flatley sells 5,000 shares of ILMN on 01/10/2013 at an average price of $52.93 a share.
Illumina, Inc. has a market cap of $6.28 billion; its shares were traded at around $52.53 with a P/E ratio of 36.6 and P/S ratio of 6. Illumina, Inc. had an annual average earning growth of 35.1% over the past 5 years.
CEO Recent Trades:
- President & CEO Jay T Flatley sold 5,000 shares of ILMN stock on 01/10/2013 at the average price of 52.93. Jay T Flatley owns at least 409,357 shares after this. The price of the stock has decreased by 0.76% since.
- President and CEO Jay T Flatley sold 10,000 shares of ILMN stock on 12/27/2012 at the average price of 55.53. Jay T Flatley owns at least 409,357 shares after this. The price of the stock has decreased by 5.4% since.
- President & CEO Jay T Flatley sold 5,000 shares of ILMN stock on 12/13/2012 at the average price of 52.74. Jay T Flatley owns at least 409,357 shares after this. The price of the stock has decreased by 0.4% since.
- President & CEO Jay T Flatley sold 5,000 shares of ILMN stock on 11/23/2012 at the average price of 53.32. Jay T Flatley owns at least 409,357 shares after this. The price of the stock has decreased by 1.48% since.
- President & CEO Jay T Flatley sold 5,000 shares of ILMN stock on 11/08/2012 at the average price of 47.99. Jay T Flatley owns at least 409,357 shares after this. The price of the stock has increased by 9.46% since.
Directors and Officers Recent Trades:
- Sr VP & General Manager Mark L Lewis sold 24,500 shares of ILMN stock on 12/20/2012 at the average price of 56.21. Mark L Lewis owns at least 41,885 shares after this. The price of the stock has decreased by 6.55% since.
- Sr VP & General Manager Mark L Lewis sold 5,000 shares of ILMN stock on 12/19/2012 at the average price of 51.87. Mark L Lewis owns at least 41,885 shares after this. The price of the stock has increased by 1.27% since.
- Sr VP & GM Molecular Biology Mark L Lewis sold 5,000 shares of ILMN stock on 11/19/2012 at the average price of 50. Mark L Lewis owns at least 41,885 shares after this. The price of the stock has increased by 5.06% since.
- Sr VP, General Manager Genomic Christian O Henry sold 10,000 shares of ILMN stock on 10/09/2012 at the average price of 51.7. Christian O Henry owns at least 37,745 shares after this. The price of the stock has increased by 1.61% since.
- Sr VP, General Manager Genomic Christian O Henry sold 30,000 shares of ILMN stock on 09/14/2012 at the average price of 48. Christian O Henry owns at least 37,745 shares after this. The price of the stock has increased by 9.44% since.
For the complete insider trading history of ILMN,
click here.
European Shorting
Feedback
My Portfolios
Browse Gurus
RSS